4D Molecular Therapeutics Inc (33) | Human Resources (14)

Browse by Subcategory

Recent Contracts

Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on May 12, 2022)
Change in Control and Severance Agreement, dated September 22, 2021, by and between Fred Kamal and 4D Molecular Therapeutics, Inc (Filed With SEC on November 10, 2021)
2020 Incentive Award Plan (Filed With SEC on December 7, 2020)
Employment Agreement, dated January 15, 2019 between Peter Francis, M.D., Ph.D. and the Registrant (Filed With SEC on December 7, 2020)
Change in Control and Severance Agreement, dated September 22, 2021, by and between August Moretti and 4D Molecular Therapeutics, Inc (Filed With SEC on September 24, 2021)
Change in Control and Severance Agreement, dated September 22, 2021, by and between David Kirn and 4D Molecular Therapeutics, Inc (Filed With SEC on September 24, 2021)
Change in Control and Severance Agreement, dated September 22, 2021, by and between Robert Stephen Fishman and 4D Molecular Therapeutics, Inc (Filed With SEC on September 24, 2021)
Form of Stock Option Grant Notice and Stock Option Agreement under the 2020 Incentive Award Plan (Filed With SEC on December 7, 2020)
Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement under the 2020 Incentive Award Plan (Filed With SEC on December 7, 2020)
Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2020 Incentive Award Plan (Filed With SEC on December 7, 2020)
2015 Equity Incentive Plan (Filed With SEC on November 17, 2020)
Form of Stock Option Agreement under 2015 Equity Incentive Plan (Filed With SEC on November 17, 2020)
2015 Equity Incentive Plan (Filed With SEC on September 30, 2019)
Form of Stock Option Agreement under 2015 Equity Incentive Plan (Filed With SEC on September 30, 2019)